BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06087263-completion@plaintrial.com
DTSTAMP:20261027T202114Z
DTSTART;VALUE=DATE:20340701
SUMMARY:Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific G
 IST Mutation Subsets (KIT Exon 17\, 18\, or 14 Mutation and SDHB Deficient
  GIST) in the Post-imatinib Second-line Setting. — estimated completion 
 date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06087263
URL:https://plaintrial.com/trial/NCT06087263
END:VEVENT
END:VCALENDAR